Author:
Khedkar Vijay M,Arya Nikhilesh,Coutinho Evans C,Shishoo Chamanlal J,Jain Kishor S
Abstract
Abstract
An investigation into the mechanism of antihyperlipidemic action of 2-chloromethyl-5,6,7,8-tetrahydrobenzo(b)thieno[2,3-d]pyrimidin-4(3H)-one (LM-1554) was carried out through docking experiments with six different molecular targets; Niemann Pick C1 Like1 protein (NPC1L1), ATP citrate lyase (ACL), C-reactive protein (CRP), lanosterol 14α-demethylase (LDM), squalene synthase (SqS) and farnesiod X-receptor (FXR) known to be implicated in the physiology of hyperlipidemia. The interactions of LM-1554 were compared with the interactions of their respective co-crystallized native ligands at the active sites of these receptors. These comparisons are based on their docking parameters, as well as, types of interactions and vicinity with various amino acids in the active site pockets. The interaction of LM-1554 with the target, NPC1L1 has been found to be the quite favourable as compared to those with the other targets assessed in this study.
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Arya VP: Drugs Future. 1985, 10(2):123-127.
2. Arya N, Dwivedi J, Khedkar VM, Coutinho EC, Jain KS: Design, Synthesis and Biological Evaluation of Some 2-Azetidinone Derivatives as Potential Antihyperlipidemic Agents. Arch Pharm Chem Life Sci 2013, 346: 872-881. 10.1002/ardp.201300262
3. Arya N, Kharjul MD, Shishoo CJ, Thakare VN, Jain KS: Some molecular targets for antihyperlipidemic drug research. Eur J Med Chem 2014. doi:10.1016/j.ejmech.2014.08.013
4. Bailey DB, Walsh DT, Warner TD: Expression and activation of the farnesoid X receptor in the vasculature. Proc Natl Acad Sci U S A 2004, 101: 3668-3673. 10.1073/pnas.0400046101
5. Calvo MG, Lisnock JM, Bull HG, Hawes BE, Burnett DA, Braun MP, Crona JH, Davis HR Jr, Dean DC, Detmers PA, Graziano MP, Hughes M, MacIntyre DE, Ogawa A, O’Neill KA, Iyer SPN, Shevell DE, Smith MM, Tang YS, Makarewicz AM, Ujjainwalla F, Altmann SW, Chapman KT, Thornberry NA: The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci U S A 2005, 102: 8132-8137. 10.1073/pnas.0500269102
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献